arrow
Back
D

Daan J.A. Crommelin

Utrecht University

80H-index
402Paper Count
2.2WCitation Count
Published Papers 112
Publication Date
In memory of Professor William I. Higuchi (1931–2024)
err2025-07-25
err0
PREAI
errBradley D. Anderson; Daniel J.A. Crommelin; James N. Herron
errShare
errSave
Stability of Protein Pharmaceuticals: Recent Advances
err2024-06-27
err2
PREAI
errManning, Mark Cornell; Holcomb, Ryan E.; Payne, Robert W.; Stillahn, Joshua M.; Connolly, Brian D.; Katayama, Derrick S.; Liu, Hongcheng; Matsuura, James E.; Murphy, Brian M.; Henry, Charles S.; Crommelin, Daan J. A.
errShare
errSave
The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case
err2023-02-01
err93
errOAAI
errBlenke, Erik Oude; Ornskov, Eivor; Schoneich, Christian; Nilsson, Gunilla A.; Volkin, David B.; Mastrobattista, Enrico; Almarsson, Orn; Crommelin, Daan J. A.
errShare
errSave
Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines
err2022-04-07
err85
errOAAI
errSzebeni, Janos; Storm, Gert; Ljubimova, Julia Y.; Castells, Mariana; Phillips, Elizabeth J.; Turjeman, Keren; Barenholz, Yechezkel; Crommelin, Daan J. A.; Dobrovolskaia, Marina A.
errShare
errSave
A Cluster of Articles in Memory of Wim Jiskoot, Ph.D
err2022-04-01
err0
PREAI
errCrommelin, Daan J. A.; Narhi, Linda O.; Das, Tapan K.
errShare
errSave
Formulation of Cell-Based Medicinal Products: A Question of Life or Death?
err2021-05-01
err14
errOAAI
errHoogendoorn, Karin H.; Crommelin, Daan J. A.; Jiskoot, Wim
errShare
errSave
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
err2021-05-01
err907
errOAAI
errSchoenmaker, Linde; Witzigmann, Dominik; Kulkarni, Jayesh A.; Verbeke, Rein; Kersten, Gideon; Jiskoot, Wim; Crommelin, Daan J. A.
errShare
errSave
Addressing the Cold Reality of mRNA Vaccine Stability
err2021-03-01
err345
errOAAI
errCrommelin, Daan J. A.; Anchordoquy, Thomas J.; Volkin, David B.; Jiskoot, Wim; Mastrobattista, Enrico
errShare
errSave
The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines
err2021-02-01
err42
errOAAI
errCrommelin, Daan J. A.; Volkin, David B.; Hoogendoorn, Karin H.; Lubiniecki, Anthony S.; Jiskoot, Wim
errShare
errSave
Identification of Formaldehyde-Induced Modifications in Diphtheria Toxin
err2020-01-01
err21
errOAAI
errMetz, Bernard; Michiels, Thomas; Uittenbogaard, Joost; Danial, Maarten; Tilstra, Wichard; Meiring, Hugo D.; Hennink, Wim E.; Crommelin, Daan J. A.; Kersten, Gideon F. A.; Jiskoot, Wim
errShare
errSave
Shifting Paradigms Revisited: Biotechnology and the Pharmaceutical Sciences
err2020-01-01
err10
errOAAI
errCrommelin, Daan J. A.; Mastrobattista, Enrico; Hawe, Andrea; Hoogendoorn, Karin H.; Jiskoot, Wim
errShare
errSave
Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare
err2019-05-31
err8
errOAAI
errde Vrueh, Remco L. A.; de Vlieger, Jon S. B.; Crommelin, Daan J. A.
errShare
errSave
The EU regulatory landscape of non-biological complex drugs (NBCDs) follow-on products: Observations and recommendations
err2019-05-01
err41
errOAAI
errKlein, K.; Stolk, P.; De Bruin, M. L.; Leufkens, H. G. M.; Crommelin, D. J. A.; De Vlieger, J. S. B.
errShare
errSave
Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: Drug Products, Including Biological Products, that Contain Nanomaterials
err2019-04-17
err18
errOAAI
errde Vlieger, Jon S. B.; Crommelin, Daan J. A.; Tyner, Katherine; Drummond, Daryl C.; Jiang, Wenlei; McNeil, Scott E.; Neervannan, Sesha; Crist, Rachael M.; Shah, Vinod P.
errShare
errSave
Postproduction Handling and Administration of Protein Pharmaceuticals and Potential Instability Issues
err2018-08-01
err86
errOAAI
errNejadnik, M. Reza; Randolph, Theodore W.; Volkin, David B.; Schoneich, Christian; Carpenter, John F.; Crommelin, Daan J. A.; Jiskoot, Wim
errShare
errSave
How to select a nanosimilar
err2017-07-17
err32
errOAAI
errAstier, Alain; Pai, Amy Barton; Bissig, Marco; Crommelin, Daan J. A.; Fluhmann, Beat; Hecq, Jean-Daniel; Knoeff, Josefien; Lipp, Hans-Peter; Morell-Baladron, Alberto; Muhlebach, Stefan
errShare
errSave
Equivalence of complex drug products: advances in and challenges for current regulatory frameworks
err2017-04-26
err58
errOAAI
errHussaarts, Leonie; Muhlebach, Stefan; Shah, Vinod P.; McNeil, Scott; Borchard, Gerrit; Fluhmann, Beat; Weinstein, Vera; Neervannan, Sesha; Griffiths, Elwyn; Jiang, Wenlei; Wolff-Holz, Elena; Crommelin, Daan J. A.; de Vlieger, Jon S. B.
errShare
errSave